Among Multiple Needle Core Biopsy Samples, the One with the Highest Tumor Proportion Score Best Represents the PD-L1 Status of the Whole Surgical Specimen in Non–Small Cell Lung Cancer. Issue 3 (March 2022)
- Record Type:
- Journal Article
- Title:
- Among Multiple Needle Core Biopsy Samples, the One with the Highest Tumor Proportion Score Best Represents the PD-L1 Status of the Whole Surgical Specimen in Non–Small Cell Lung Cancer. Issue 3 (March 2022)
- Main Title:
- Among Multiple Needle Core Biopsy Samples, the One with the Highest Tumor Proportion Score Best Represents the PD-L1 Status of the Whole Surgical Specimen in Non–Small Cell Lung Cancer
- Authors:
- Sun, Wei
Yang, Xin
Wang, Haiyue
Wu, Jianghua
Chen, Mailin
Liu, Changling
Hu, Di
Huang, Xiaozheng
Jia, Ling
Kang, Qiang
Wu, Qi
Diao, Xinting
Zhou, Lixin
Lin, Dongmei - Abstract:
- Abstract : The heterogeneity of programmed death-ligand 1 (PD-L1) status between core needle biopsies (CNBs) from one tumor has not been well studied before. The current study attempts to find out the best index using multiple core biopsies from one tumor which can better reflect the actual PD-L1 status. Random CNB was performed in surgical specimens from 170 consecutive non–small cell lung cancer samples. Fifty-one cases (41 cases with PD-L1 positive and 10 cases with PD-L1 negative) and 216 matched CNBs were analyzed by DAKO 22C3 PharmDx Link 48 Autostainer. The PD-L1 status was compared between the surgical specimens and matched CNBs. Heterogeneity of PD-L1 status between CNBs from one tumor was observed in 56% of PD-L1 positive cases. Different tumor proportion score (TPS) statistical forms with regard to the highest, mean, median, weighted average TPS, as well as TPS showed by the longest biopsy specimen and the biopsy with most tumor volume were compared. At a cut-off of 1%, the concordance rates were 94.1%, 88.2%, 90.2%, 86.3%, 86.3%, and 86.3%; At a cut-off of 50%, the concordance rates were 92.2%, 86.3%, 84.3%, 82.4%, 82.4%, and 86.3%, respectively. The CNB with the highest TPS can best represent PD-L1 status estimated by whole surgical specimen. The highest TPS among the multiple biopsies is a robust evaluation of the PD-L1 status, but not mean TPS, at the 1% and 50% cut-offs.
- Is Part Of:
- Applied immunohistochemistry & molecular morphology. Volume 30:Issue 3(2022)
- Journal:
- Applied immunohistochemistry & molecular morphology
- Issue:
- Volume 30:Issue 3(2022)
- Issue Display:
- Volume 30, Issue 3 (2022)
- Year:
- 2022
- Volume:
- 30
- Issue:
- 3
- Issue Sort Value:
- 2022-0030-0003-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-03
- Subjects:
- non–small cell lung cancer -- PD-L1 -- biopsy -- resection specimen
Diagnostic immunohistochemistry -- Periodicals
Immunohistochemistry -- Periodicals
Cells -- Morphology -- Periodicals
Molecular diagnosis -- Periodicals
616.079 - Journal URLs:
- http://journals.lww.com/appliedimmunohist/pages/default.aspx ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/PAI.0000000000000985 ↗
- Languages:
- English
- ISSNs:
- 1541-2016
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 1573.140000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 26606.xml